Prostate Adenocarcinoma

Showing 51 - 75 of 187

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Laboratory Biomarker Analysis
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 19, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Moscow (consequently performed 4 biopsy methods (TRUS-guided biopsy,

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • consequently performed 4 biopsy methods (TRUS-guided biopsy, cognitive, fusion and transperineal template mapping biopsy)
  • Moscow, Russian Federation
    Institute for Urology and Reproductive Health, Sechenov Universi
Oct 18, 2022

Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +259 more
Oct 19, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

Recruiting
  • Prostate Adenocarcinoma
  • +7 more
  • High-Dose Rate Brachytherapy
  • Stereotactic Body Radiation Therapy
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • San Francisco, California
  • +1 more
Oct 8, 2022

Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance

Recruiting
  • Prostate Adenocarcinoma
  • Prostate Cancer
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Oct 3, 2022

Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States

Recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Gonadotrophin Releasing Hormone
  • +2 more
  • Gilbert, Arizona
  • +86 more
Sep 27, 2022

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Prostate-Specific Membrane Antigen PET Scans in People Prostate

Recruiting
  • Prostate Cancer
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 29, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 23, 2022

Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,

Not yet recruiting
  • Oligometastatic Prostate Carcinoma
  • +3 more
  • Lutetium Lu-177 PNT2002
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Aug 15, 2022

Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)

Completed
  • Prostate Adenocarcinoma
  • F-18 fluciclovine-PET/CT scan
  • Tucson, Arizona
    University of Arizona
Aug 12, 2022

Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

Recruiting
  • Oligometastatic Prostate Carcinoma
  • +2 more
  • Placebo Administration
  • +3 more
  • Decatur, Illinois
  • +2 more
Aug 11, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Radical Prostatectomy
  • TULSA Procedure
  • Tarzana, California
  • +7 more
Aug 10, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 Trial in San Francisco (Angiogram,

Recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Angiogram
  • +3 more
  • San Francisco, California
    University of California San Francisco
Aug 5, 2022

Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Houston (Fluorine F

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +2 more
  • Fluorine F 18 rhPSMA-7.3
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Aurora, Denver (Ga-PSMA-11)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Aurora, Colorado
  • +1 more
Jul 28, 2022

Prostate Adenocarcinoma Trial in Haifa (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))

Recruiting
  • Prostate Adenocarcinoma
  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
  • Haifa, Israel
  • +1 more
Jul 4, 2022

Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Tucson, Arizona
  • +4 more
Jun 28, 2022

Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United

Active, not recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Hypofractionated radiation therapy
  • +2 more
  • Birmingham, Alabama
  • +240 more
Jun 6, 2022

Prostate Adenocarcinoma Trial in United States (Illuminare-1, Karl Storz D-Light C photodynamic diagnostic (PDD))

Recruiting
  • Prostate Adenocarcinoma
  • Illuminare-1
  • Karl Storz D-Light C photodynamic diagnostic (PDD)
  • Basking Ridge, New Jersey
  • +5 more
Jun 20, 2022